A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Itchy eyes can be uncomfortable, even crazy-making, and many of us experience them at one time or another. If you’re ...

A focused update to AAD’s adult AD guidelines recommends tapinarof, roflumilast, lebrikizumab, and nemolizumab based on ...

Mental health treatment is on the rise among adults overall — up from 19.2% in 2019 to 21.6% in 2021. However, ...

The new branding showcases the Company's innovative vision for the future and mission to redefine the retina experience ...

Nektar Therapeutics said on Tuesday its lead drug candidate met the main goal of a mid-stage study testing the drug in eczema patients, sending its shares up by nearly 140%. In the 393-patient global ...

Beyond the classic symptoms of watery eyes and sniffles, there are more unusual ones, which can be mistaken for other things.

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.

The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.